Philippines Approves Pfizer-BioNTech Vaccine for Emergency Use
The Philippines has approved Pfizer-BioNTech’s COVID-19 vaccine, the first to be allowed for emergency use in the South-east Asia nation. Thursday, January 14,…
China’s Sinovac Vaccine has been Found to be 50% Effective
China’s Sinovac coronavirus vaccine has been found to be 50.4% effective in Brazilian clinical trials, according to the latest results released by researchers.…
Philippines Seeks 50M of COVID-19 Vaccine Shots in 2021
The Philippines aims to have at least 50 million coronavirus vaccine shots in 2021 to vaccinate about a fourth of the population. The…
Inhaled Vaccines Aim to Fight Coronavirus Pandemic
Vaccines sprayed into the nose or inhaled through the mouth won’t require needles and could be easier to roll out and be more…
30K Volunteers: World’s Biggest COVID-19 Vaccine Study Begins
Monday, July 27, the world’s biggest COVID-19 vaccine study begins with the first of 30,000 planned volunteers. The volunteers are helping to test…
AstraZeneca Positive News on Coronavirus Vaccine
AstraZeneca and the University of Oxford are set to share “positive news” on their coronavirus vaccine. AZD1222, a recombinant adenovirus vaccine candidate that…
AstraZeneca Targets 2B doses for Coronavirus Vaccine
AstraZeneca announced a series of deals on Thursday, June 4, that will double its manufacturing capacity to 2 billion doses for a potential…
AstraZeneca get $1B from U.S to make COVID-19 Vaccine
British pharmaceuticals group, AstraZeneca, had secured more than $1.0 billion from the U.S to help fund the production of its COVID-19 vaccine. AstraZeneca…
Candidate Vaccine: Moderna COVID-19 Generates Immune Response
Moderna Inc. a candidate vaccine for COVID-19 appears to generate positive interim data in the first phase of the coronavirus vaccine trial.
ASEAN HR TECH VENTURE SUMMIT 2018
REGISTER NOW 33% DISCOUNTSUMMIT PASS
Get your tickets now for the
ASEAN HR TECH VENTURE SUMMIT 2018
Sign Up now for the Malacañan Tour
MALACAÑAN TOUR IS AVAILABLE BUT FOR LIMITED SEATS ONLY FOR Sponsorship, Exhibitor and Full Paying Attendees.
If you are one of the above, click the button below to contact us and process your application. Please prepare your conference ID from your registration.
If you have questions about the status of your application or how to obtain access to our events, you can email [email protected]
Send this to a friend